Validation of the Friedewald Formula in Patients with Metabolic Syndrome

Currently, the Friedewald formula (FF) is the main method for evaluating low-density lipoprotein cholesterol (LDL-c). Recently, many limitations have emerged regarding its use, including patients with triglyceride levels ≥400 mg/dL, diabetes mellitus, and kidney or hepatic chronic diseases. We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Knopfholz, José, Disserol, Caio César Diniz, Pierin, Andressa Jardim, Schirr, Fernanda Letícia, Streisky, Larissa, Takito, Lilian Lumi, Massucheto Ledesma, Patrícia, Faria-Neto, José Rocha, Olandoski, Marcia, da Cunha, Claudio Leinig Pereira, Bandeira, Antonio Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941209/
https://www.ncbi.nlm.nih.gov/pubmed/24672715
http://dx.doi.org/10.1155/2014/261878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941209/
https://www.ncbi.nlm.nih.gov/pubmed/24672715
http://dx.doi.org/10.1155/2014/261878

Ejemplares similares